MedTrace Pharma

About:

MedTrace helps doctors diagnose critically ill patients faster and more accurately.

Twitter/X: MedTraceAS

Top Investors: European Innovation Council, Vaekstfonden, ATP, BankInvest, Syddansk Innovation

Description:

MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner. By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at the same time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.

Total Funding Amount:

$52.3M

Headquarters Location:

Lyngby, Hovedstaden, Denmark

Founded Date:

2015-01-05

Contact Email:

connect(AT)medtrace.dk

Founders:

Hans Harms, Jens Soerensen, Lars Tolbod, Mark Lubberink, Martin Stenfeldt, Peter Larsen, Rune Wiik Kristensen

Number of Employees:

11-50

Last Funding Date:

2023-09-21

IPO Status:

Private

Industries: